SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Immunotherapy

    Archives: Immunotherapy

    Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.  Dec 31, 2008
    NEW BRUNSWICK, N.J., Dec. 30 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: ) today announced the completion of its previously announced acquisition of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products. Omrix is expected to operate as a stand-alone entity reporting through ETHICON, Inc., a Johnson & Johnson company. (PR Newswire)

    One holiday wish: A last game to cheer  Dec 27, 2008
    And interferon and immunotherapy. Her beautiful blonde hair fell out, and she's lost so much weight that she's unrecognizable. (OregonLive, OR -- Sports)

    Paladin Labs Inc. Acquired ViRexx Medical Corp.  Dec 23, 2008
    OvaRex MAb was subject to one Phase II study examining combination chemo-immunotheray in front-line treatment, and two randomized, double blind and placebo controlled Phase III clinical trials examining immunotherapy during remission. BrevaRex MAb was shown to be safe in a Phase I clinical trial in patients with MUC-1 expressing tumours. (CCNMatthews Press Releases)

    M. D. Anderson neurosurgeon, Amy Heimberger, M.D., receives presidential award  Dec 20, 2008
    With the award, Heimberger's research grant from the National Cancer Institute (NCI) studying the role of immunotherapy in glioma, will be automatically renewed ... She has directly applied her laboratory evaluations of the immune responses within the tumor micro-environment to design pivotal immunotherapy clinical trials for patients with glioblastoma. (EurekAlert!)

    Valley researchers join for cancer-drug tests  Dec 19, 2008
    Cohen, who recently joined Mayo from Cleveland Clinic, said scientists have long sought strategies to fight cancer through immunotherapy, and even some research has been remarkably similar to VentiRx's approach, albeit with one key difference. Past research has tested "toll-like receptors 7 and 9" molecules, targets that have proven effective in mice but not humans, Cohen said. (AZCentral -- Business)

    Why kids get sicker at night  Dec 18, 2008
    Should you find that her attacks are frequent and occur year-round, you may want to consider immunotherapy shots, which introduce tiny amounts of the allergen into the body, slowly allowing immunity to build. Got an asthmatic. (CNN -- Law)

    Hope For The Treatment Of Systemic Lupus Erythematosus  Dec 16, 2008
    Muller et al. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial. Arthritis & Rheumatism, 2008; 58 (12): 3873 DOI. (Science Daily)

    Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration  Dec 16, 2008
    Within this collaboration, Generex wholly-owned immunotherapy subsidiary Antigen Express, Inc. combines Pevion Biotech's virosome technology with its own technology and is conducting trials in patients with breast, prostate and ovarian cancer. The combination of the two technologies will stimulate different portions of the immune system. (Primezone Releases)

    BETTER LIFE:  Sexual health news  Dec 12, 2008
    Sexual health - Better Life - USATODAY.com. Review finds abortion doesn't cause mental health problems. (USA Today -- Tech)

    Enzyme May Hold Key To Successfully Treating Pancreatic Cancer With Targeted Immunotherapy  Dec 11, 2008
    10, 2008) An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association. See also. (Science Daily)

    Towards Improved Immunotherapy  Dec 11, 2008
    Immunotherapy refers to a collection of treatments based upon the concept of modulating the immune system to achieve a prophylactic and/or therapeutic goal ... Michael Albert and colleagues from the Ludwig-Maximilians-University in Munich, Germany, describe a unique strategy that facilitates the induction of regulatory T cells ex vivo with subsequent expansion to numbers adequate for immunotherapy. (Science Daily)

    Harnessing MiRNA Natural Gene Repressors For Anticancer Therapy  Dec 9, 2008
    The authors therefore suggest that it might be possible to harness miRNA-regulated therapeutic gene expression in stem cell based therapies, including cancer immunotherapy. Journal reference. (Science Daily)

    Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months  Dec 8, 2008
    Subsequent therapy with various modalities including chemotherapy, radiotherapy, immunotherapy, Zevalin and stem cell transplation (ASCT) was given to 63 patients in the Zevalin arm and 108 patients in the control arm, who achieved an overall response rate of 81% and 73%, respectively ... Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, low-grade or... (PR Newswire)

    Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders  Dec 8, 2008
    This multicenter phase III study is the first to prospectively determine that adding the immunotherapy drug rituximab to dexamethasone (a steroid that is a standard therapy for ITP) is safe and effective in adult patients with previously untreated idiopathic thrombocytopenic purpura (ITP). The results of this study indicate that this treatment regimen could be an effective option prior to splenectomy for some patients as well as a possible cure for others. (PR Newswire)

    Scientists Developing Safer Food Allergy Treatment  Dec 4, 2008
    Attempted treatment with allergen-specific immunotherapy, where a patient received monthly injections with an allergen extract for three to five years, failed because it could cause anaphylaxis as a side effect. Anaphylaxis is a severe allergic reaction involving the whole body, often within minutes of exposure to the allergen. (Science Daily)

    Immunomedics to Present At 50th ASH Annual Meeting  Dec 2, 2008
    --"Radioimmunotherapy of Non-Hodgkin Lymphoma is Improved without Increasing Toxicity by Combination with Antibody Immunotherapy" (Publication No. 1588, Session Name: Lymphoma: Pre-Clinical - Chemotherapy and Biologic Agents Poster I, Saturday, December 6, 5:30 p.m. - 7:30 p.m., Board # I-693, Moscone Center, Hall A) --"A Novel Anti-CD20 IgG-Interferon-alpha2b Fusion Protein with Potent in Vitro and in Vivo Anti-Lymphoma Activity Made by the Dock-and-Lock (DNL) Method" (Publication No. 1590,... (Primezone Releases)

    Nothing To Sneeze At  Nov 27, 2008
    When drugs aren't enough, allergists often turn to immunotherapy. In immunotherapy, patients are repeatedly injected under the skin with small amounts of the allergen in doses that are slowly increased over time ... Many patients put up with allergies rather than deal with the nuisance and expense of immunotherapy, though a life-threatening allergy to, say, bee stings might make it worthwhile. (Slate)

    Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile  Nov 24, 2008
    The presentation, entitled, "Patients Age in Bladder Cancer Immunotherapy Response and Adverse Events: MCC Experience", was presented by Dr. Fran;ois Charette, Senior Vice-President and Chief Medical Officer of Bioniche Life Sciences Inc. In his presentation, Dr. Charette summarized the results of Phase I/II clinical studies with MCC, which involved 130 patients with Carcinoma in situ (CIS) high grade bladder cancer, with or without papillary lesions. The majority of these patients (62%) had... (Canada Newswire)

    Smoking Causes Bladder Cancer  Nov 17, 2008
    Bladder cancer can be treated by removing the tumors, administering intravesical chemotherapy and immunotherapy, or cystectomy (complete removal of the bladder). Bladder cancer is most treatable when caught early. (Newsmax)

    Lymph Node Shots Tested for Grass Pollen Allergy  Nov 12, 2008
    The result: "Less than 5 percent of allergy patients are treated with allergen-specific immunotherapy," Kundig said. To test the potential of lymph node shots, the Swiss-American team focused on just under 100 patients between the ages of 18 and 65. (U.S. News & World Report)

    Mia Zito Glitz and GlamAids Seymour Youngster With Melanoma  Nov 12, 2008
    "She's getting alpha-interferon immunotherapy," her mother told Voices. "It's used in adults, but it's a trial in small children. They were able to get rid of the cancer cells, but this is to make sure it doesn't come back and grow in her lymph nodes again."She's so strong, so brave," said Christine. "The doctor told me that children are resilient, but I've never seen such strength. (Voices, CT)

    New treatment desensitizes children's allergies  Nov 11, 2008
    The clinic sees more than 10,000 patients a year who come for sublingual immunotherapy or the placing of tiny drops of the allergen under the tongue to stimulate the oral mucosa. According to the clinic, 43 states are using the LaCrosse method to treat patients with food and other allergies. (Atlanta Journal-Constitution -- Health)

    Generex Biotechnology Corporation's Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC  Nov 10, 2008
    BOSTON, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology (NasdaqCM: - ) announces that Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation, entitled, ``Breaking-out the Sum of the Parts: Antigen Express' Novel Cancer Immunotherapy Emerges as a Jewel. . (Primezone Releases)

    Protein-printing Technique Gives Snapshots Of Immune System Defense  Nov 9, 2008
    Moreover, Love says, further development of the technique could make it possible to quickly determine whether an infection is bacterial or viral, figure whether a cancer patient has built up enough "immunity" to his or her cancer to forgo another round of immunotherapy, and obtain complete profiles of an immune response with as little as a drop of blood a crucial ability when testing infants and children. Adapted from materials provided by. (Science Daily)

    Improving the Use of Drugs Through Genes  Nov 8, 2008
    Surgery, chemotherapy, radiation, immunotherapy. Know your options. (Yahoo News -- Pharmaceutical Industry News)

    Double-barreled Immune Cell Approach For Neuroblastoma  Nov 6, 2008
    3, 2008) A novel anti-tumor vaccine for neuroblastoma and melanoma is showing significant impact on tumor growth in mice, according to new research published in Cancer Immunology, Immunotherapy. The vaccine. (Science Daily)

    Tailored Treatment Boosts Kidney Cancer Survival  Nov 4, 2008
    For example, the UCLA team showed that surgery alone can produce excellent outcomes in patients with localized, low-risk, kidney cancer, meaning they could be spared the harsh side effects associated with radiation or immunotherapy. But surgery alone isn't sufficient for patients with localized, high-risk kidney cancer. (MEDLINEplus)

    More milk best way to treat milk allergy: study  Nov 2, 2008
    Oral immunotherapy, as the group of researchers called this repeated exposure, is so far the only possible way to treat childhood food allergy. Many children cannot digest milk and suffer allergic reactions ranging from itchy mouth and wheals to stomach disorders such as mild pain or runny tummy. (Little About)

    Oral immunotherapy with milk can cure milk allergies  Nov 1, 2008
    Albeit preliminary and requiring further study, these results suggest that oral immunotherapy may be the closest thing yet to a 'true' treatment for food allergy. " Children between 6 to 17 years of age were studied by researchers. One group was given milk powder while other was given placebo, which looked and tasted like milk powder. 19 children reported constant severe allergies for about four months. Out of these, 12 children were administered higher doses of milk and others were given... (TheMedGuru)

    Farmington woman seeks cancer treatment  Nov 1, 2008
    On the Web site, the Issels treatment is described as a comprehensive Immunotherapy program that is designed to stimulate the body's own regulatory, repair and immune mechanisms, to recognize and eliminate cancer cells. It integrates effective state-of-the-art technologies, such as cancer vaccines, and other research-based therapies. (Park Hills Daily Journal, MO)

    Drinking Milk To Ease Milk Allergy? Oral Immunotherapy Study Shows Promise -- But Do Not Try This At Home  Nov 1, 2008
    Oral Immunotherapy Study Shows Promise -- But Do Not Try This At Home ... Oral Immunotherapy Study Shows Promise -- But Do Not Try This At Home ... Despite the small number of patients in the trial 19 the findings are illuminating and encouraging, investigators say, because this is the first-ever double-blinded and placebo-controlled study of milk immunotherapy. (Science Daily)

    Cancer Requires Support From Immune System To Develop  Nov 1, 2008
    31, 2008) Tumors that grow around nerves in a rare genetic disease need cooperation from cells from the immune system in order to grow, reports a team of scientists, including researchers from UT Southwestern Medical Center. Treating mice with a drug that attacks the immune cells not the tumor greatly reduced the size and metabolism of the tumors, the scientists reported. (Science Daily)

    Landmark UCLA study finds aggresive, personalized treatment increases kidney cancer patient survival  Nov 1, 2008
    Such a move would spare the patient from having to undergo radiation or immunotherapy, which result in harsh side effects ... Additional therapy such as targeted treatments or immunotherapy should be considered in order to give the patient the best possible outcome. (EurekAlert!)

    ACE Inhibitor Drugs Okay with Venom Therapy  Oct 30, 2008
    The treatment, known as venom immunotherapy, involves exposure to tiny amounts of venom that activates a small allergic reaction ... In a report published in the medical literature this month, Dr. Kevin M. White and Dr. Ronald W. England of Wilford Hall Medical Center, San Antonio, note that there have been several case reports of severe system-wide reactions in venom allergic and other patients taking ACE inhibitors who have been stung or exposed to venom immunotherapy ... Their current... (MEDLINEplus)

    Clostridium difficile — More Difficult Than Ever  Oct 30, 2008
    NEJM -- Clostridium difficile -- More Difficult Than Ever. Volume 359:1932-1940. (New England Journal of Medicine)

    Immunotherapy on Trial for New-Onset Type 1 Diabetes  Oct 30, 2008
    Volume 359:1956-1958. Denise L. Faustman, M.D., Ph. (New England Journal of Medicine)

    Drink Milk to Ease Milk Allergies?  Oct 29, 2008
    Despite the small number of patients in the trial 19 the findings are illuminating and encouraging, investigators say, because this is the first-ever double-blinded and placebo-controlled study of milk immunotherapy ... Our findings suggest that oral immunotherapy gradually retrains the immune system to completely disregard or to better tolerate the allergens in milk that previously caused allergic reactions, says Robert Wood, M.D., senior investigator on the study and director of Allergy... (Newsmax)

    Adeona Pharmaceuticals' Oral dnaJP1 Phase II Clinical Findings Presented At the American College of Rheumatology Annual Meeting  Oct 28, 2008
    A presentation titled, ``Susceptibility to Epitope-Specific Immunotherapy of Rheumatoid Arthritis Relies on the Expression of Co-stimulatory Molecules Associated with T-Cell Anergy and Tolerance'' was given by Dr. Salvatore Albani, chairman of the Department of Rheumatology at the University of Arizona and inventor of this program (contributing authors and their respective affiliations are listed below) ... Oral dnaJP1 is an epitope-specific immunotherapy for RA patients. (Primezone Releases)

    Cancer Vaccine Shows Promise In Patients With Bowel, Kidney And Prostate Cancer  Oct 27, 2008
    In recent years, the concept of vaccine immunotherapy for. (Mar. (Science Daily)

    Chronic Inflammation Can Help Nurture Skin Cancer, Study Shows  Oct 24, 2008
    "Inflammation should really help prevent a tumor," says Dr. Andrew Mellor, director of the MCG Immunotherapy Center and Georgia Research Alliance Eminent Scholar in Molecular Immunogenetics. In fact, there is strong evidence that inflammation triggers the immune response. (Science Daily)

    T Cell Response To New Melanoma Antigen Linked To Relapse-free Survival  Oct 23, 2008
    This strategy called adoptive immunotherapy causes tumor regression in about half the patients treated, some of whom survive for decades without relapse. The French team, lead by Dr. Nathalie Labarriere, studied the infused cells from 30 stage III melanoma patients who had received adoptive immunotherapy between 1994 and 1998 ... The association of meloe-1-specific T cells with relapse-free survival suggests that amplifying these T cells in culture may be one way to improve the efficacy of... (Science Daily)

    Sputtering Cell Genesys firing most employees  Oct 18, 2008
    "Personally, I have not lost my conviction about the potential of the GVAX platform or active immunotherapy in general," Sherwin said on the conference call. He said the disappointing results in the two large GVAX trials may have stemmed from factors other than the treatment itself. (San Francisco Chronicle -- Technology)

    Can A Laser Cure Your Allergies?  Oct 15, 2008
    The final step is immunotherapy, which is still under rigorous study by scientists. What Is Immunotherapy ... Administered by shot or tablet under the tongue, immunotherapy "involves giving a person increasingly higher doses of their allergen over time," according to a description from AAFA. "For reasons that we do not completely understand, the person gradually becomes less sensitive to that allergen.". (Click2Houston, TX)

    New Vaccine May Help Type 1 Diabetics in Future  Oct 10, 2008
    The hope is that the vaccine he and his team developed -- which was administered the first day of the study and then again at day 30 -- will work in a similar manner to allergy immunotherapy and help the body learn to tolerate GAD again. The study included 70 children between the ages of 10 and 18 who had been diagnosed with type 1 diabetes no more than 18 months before the start of the study. (MEDLINEplus)

    • Melanoma the most serious form of skin cancer  Oct 10, 2008
    Others may require chemotherapy, radiation or immunotherapy. Clinical trials are new therapy studies that have yet to be approved for melanoma treatment. (Burley South Idaho Press, ID)

    Novel Anti-tumor Vaccine Developed  Oct 4, 2008
    3, 2008) A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal Cancer Immunology, Immunotherapy ... In recent years, the concept of vaccine immunotherapy for. (Science Daily)

    Rapid Fire-Ant Sting Desensitization OK in Kids  Oct 3, 2008
    The one-day protocol, "which can safely reach a protective dose of immunotherapy in a short amount of time, would be a therapeutic option for any-age patient with imported fire ant allergy.". Tankersley, from Lackland Air Force Base, San Antonio, Texas and colleagues describe three children 36 months or younger who completed a one-day rapid immunotherapy protocol with imported fire ant whole-body extract ... After the rapid desensitization, the children went on to monthly maintenance... (MEDLINEplus)

    'Allergic Girl' teaches allergy-free dining  Sep 18, 2008
    The largest group of studies on the subject are in progress, including immunotherapy for people with peanut and milk allergies, she said. The majority of food allergy cases -- about 80 percent -- are "cyclic," with mild symptoms that resemble those of pollen or dust allergies: sneezing, itchy eyes, and nasal congestion, said Dr. Alpen Patel, assistant professor of otolaryngology at Emory University. (CNN -- Health)

    Illness forces band director to retire  Sep 14, 2008
    It is resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy. Targeted cancer therapies such as sunitinib have improved the outlook for RCC, although they have not yet demonstrated improved survival. (Atmore Advance, AL)

    Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain  Sep 11, 2008
    As noted above, DCVax(R)-Brain is a personalized immunotherapy designed to stimulate a patient's own immune system to fight cancer ... About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. (PR Newswire)

    Scientists Identify Genetic Link That May Neutralize HIV  Sep 8, 2008
    "We now have a host factor needed for the production of neutralizing antibodies that HIV targets and destroys," said Gladstone scientist Mario Santiago, PhD. "This offers a fresh perspective on how to strengthen this arm of the immune response against HIV, with direct implications for immunotherapy and vaccine development.". The scientists conducted a series of genetic experiments by mating mice with different Rfv3 and Apobec3 profiles. (Science Daily)

    Cancer Immunotherapy  Sep 4, 2008
    To the Editor: In his review of cancer immunology, Finn (June 19 issue)1 states that the results of immunotherapy involving intravenous administration of tumor-specific autologous T cells (adoptive cell therapy) are "marginal," whereas the results of trials of cancer vaccines are "encouraging." We do not believe this conclusion accurately reflects the state of the field. In 1994, we reported a 34% objective response rate among patients with metastatic melanoma who were treated with adoptive cell... (New England Journal of Medicine)

    Bone Marrow Transplantation  Aug 29, 2008
    Written by acknowledged world experts, it includes a comparison of different stem cell sources, and looks at reduced intensity allografting, cellular immunotherapy and post transplant relapse. Guest edited by Mitchell S. Cairo and Helen Heslop, this special issue is the first of its kind. (Nature News Service)

    Cancer Gene Therapy  Aug 29, 2008
    It publishes original laboratory and clinical research papers, case reports and review articles on topics including RNAi approaches, drug resistance, hematopoietic gene transfer, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors,translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA ymes), apoptosis; mechanisms and therapies , vaccine development, immunology and... (Nature News Service)

    Cell Genesys shares recover slightly, up 30%  Aug 29, 2008
    Vital-2 was the second of two Phase 3 clinical trials of Gvax immunotherapy for prostate cancer. Reader Comments. (San Jose Business Journal, CA)

    Alternative Vaccine Strategy Shows Promise In Prostate Cancer Patients  Aug 26, 2008
    In recent years, the concept of vaccine immunotherapy for. (July 8, 2002) A new vaccination strategy targeting telomerase, one of the enzymes responsible for making cancer cells immortal, has been tested by Professor Trond Buanes on patients with pancreatic cancer at. (Science Daily)

    Bioniche Animal Health Immunotherapy Now Listed as "Organic" for Use in Cattle  Aug 25, 2008
    QUICK SEARCH BY ORGANIZATION. FREE SUBSCRIPTION SERVICES. (Canada Newswire)

    New Lymphoma Drug Shows Promise  Aug 16, 2008
    THURSDAY, Aug. 14 (HealthDay News) -- Preliminary results from an early trial of a new immunotherapy suggests doctors may soon have another weapon for the treatment of non-Hodgkin lymphoma. A team of German scientists and clinicians led by Patrick Baeuerle, chief scientific officer at Micromet AG, a Munich-based biopharmaceutical company, demonstrated partial or complete tumor regression in 11 of 38 human patients given low doses of blinatumomab, a protein that tethers tumor-killing T-cells to... (MEDLINEplus)

    Cancer and immunotherapy Q and A  Aug 16, 2008
    What is immunotherapy ... Gradually, however, tumour cells get selected by a Darwinian process of survival of the fittest, so that they begin to shrug off T cells and immunotherapy becomes less effective ... Has immunotherapy been used before. (Telegraph.co.uk)

    Personalized immunotherapy to fight HIV/AIDS  Aug 16, 2008
    Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Skaly from the Universit de Montral, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients ... "Our approach is unique in the world: no one else has yet developed customized immunotherapy using the virus from individual patients," said Dr. Routy ... This immunotherapy is based on the properties of dendritic... (EurekAlert!)

    Roche in $43.7bln bid for last Genentech shares  Aug 15, 2008
    Josef M. Issels, M.D., developed a Comprehensive Immunotherapy for cancer and achieved complete remission of "incurable cancers" without further recurrence for up to four decades. www. (Yahoo News -- Pharmaceutical Industry News)

    Dendreon begins more testing of Provenge prostate cancer drug  Aug 15, 2008
    The other is a 40-subject, single-center trial called its neoadjuvant active cellular immunotherapy trial. Dendreon said prostate cancer is the most common nonskin cancer in the U.S., affecting more than 1 million men in the country; nearly 29,000 men will die from the disease this year. (Puget Sound Business Journal, WA)

    Allergies May Be Worse On Warming Earth  Aug 14, 2008
    Allergy shots and immunotherapy are successful treatments for treating ragweed allergy patients, he said. AAAI also suggests that patients protect themselves from direct exposure to the ragweed pollen by keeping windows closed and staying indoors when pollen counts are highest. (Click2Houston, TX)

    Scientists Use Old Enemy To K.O. Cancer  Aug 14, 2008
    13, 2008) Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard according to new research. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy oxidants as an ally. (Science Daily)

    Multi-tasking Molecule Holds Key To Allergic Reactions  Aug 9, 2008
    8, 2008) As the summer approaches most of us rejoice, reach for the sunscreen and head outdoors. But an ever-growing number of people reach for tissue instead as pollen leaves eyes watering, noses running and spirits dwindling. (Science Daily)

    Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology's Novel Immunotherapeutic Vaccine  Aug 7, 2008
    Both pre-clinical and clinical studies have shown the importance of activation of this cell type for successful cancer immunotherapy. The trial is being conducted as part of a collaboration between Antigen Express, Dr. George Peoples at the Brooke Army Medical Center and the Mary Crowley Cancer Center, which is funding the trial. (Primezone Releases)

    Immunotherapy Boosts Treatment of Kids' High-Risk Sarcomas  Aug 4, 2008
    MONDAY, Aug. 4 (HealthDay News) -- Immunotherapy shows promise in treating children with high-risk sarcomas, according to a U.S. National Institute of Health pilot study ... The study of 52 patients with recurrent and/or metastatic Ewing's sarcoma or alveolar rhabdomyosarcoma also found that those who received immunotherapy had better-than-normal survival ... Patients who received immunotherapy had a 43 percent five-year overall survival, compared to 31 percent for those who didn't receive... (Health-Finder)

    Immunotherapy in high-risk pediatric sarcomas shows promising response  Aug 1, 2008
    PHILADELPHIA Based on a pilot study in children with sarcoma, researchers at the National Institutes of Health (NIH) believe that immunotherapy could prove beneficial in treating high-risk forms of this cancer ... The 22 enrolled patients who did not receive immunotherapy had a 31 percent five-year overall survival, compared to 43 percent five-year survival in 30 patients who ultimately received the novel immunotherapy ... "We need new therapies. While outcomes overall for these tumors have... (EurekAlert!)

    NYU Langone Medical Center's tip sheet to the International Conference on Alzheimer's Disease 2008  Jul 26, 2008
    Tau Immunotherapy Prevents Cognitive Decline in an Alzheimer's Mouse Model Einar M. Sigurdsson, PhD, Assistant Professor of Psychiatry and Pathology, NYU Langone Medical Center EMBARGOED FOR RELEASE UNTIL WEDNESDAY, JULY 30, 2008 at 3:45 p.m. CT ... Tests confirmed that the immunotherapy helped preserve cognition as well as reduced tau protein tangles in the brain ... The findings support the possibility of an immunotherapy that treats Alzheimer's disease by directly targeting toxic forms of the... (EurekAlert!)

    Conductor James Levine had malignant kidney growth  Jul 24, 2008
    Further surgery, treatment with targeted therapies or immunotherapy could be considered in cases of cancers that recur after initial surgery, the American Cancer Society says on its Web site ... Treatments such as targeted therapy, chemotherapy, radiation therapy or immunotherapy are usually not recommended after surgery for early stage kidney cancer except as a part of a clinical trial, according to the American Cancer Society. (Alexander City Outlook, AL)

    Achilles Heel Of HIV Pinpointed?  Jul 16, 2008
    Pathologists Believe They Have Pinpointed Achilles Heel Of HIV. Pathologists Believe They Have Pinpointed Achilles Heel Of HIV. (Science Daily)

    Researchers Locate And Image Prostate Cancer As It Spreads To Lymph Nodes  Jul 15, 2008
    (May 23, 2001) Researchers at UCLA s Jonsson Cancer Center have shown for the first time that immunotherapy delivered via gene therapy may prove to be a potent weapon in the fight against locally advanced. . (Science Daily)

    Byrd Institute researchers get Alzheimer's grants  Jul 13, 2008
    Chuanhai Cao was awarded $50,000 by the Parkinson's Research Foundation to continue developing his innovative approach to immunotherapy. Jaya Padmanabhan received a three-year $240,000 grant from the Alzheimer's Association to continue her work on the regulatory functions of inflammatory proteins in Alzheimer's disease. (Tampa Bay Business Journal, FL)

    Kidney Cancer Vaccine Shows No Boost in Survival  Jul 5, 2008
    The field of cancer immunotherapy is weakened when some researchers and vaccine companies are reluctant to accept the results of randomized clinical trials, Yang said. "Commercially driven efforts that spin or obfuscate the conclusions of such a trial should be vigorously resisted because such efforts severely erode its value," he concluded. (MEDLINEplus)

    Alzheimer's Drug Shows Early Promise  Jul 1, 2008
    "This is the first study of adequate size and duration that suggests the immunotherapy beta-amyloid model works," said Dr. Anton Porsteinsson, an associate professor of psychiatry at the University of Rochester School of Medicine who was one of the investigators for the study. "Immunotherapy is a huge front in the development of treatments." ... Immunotherapy, an emerging frontier for a variety of different diseases, involves stimulating the body's own immune system to fight various conditions,... (MEDLINEplus)

    Silencing Of Molecular 'Conversation' May Help Curb Severe Allergies  Jul 1, 2008
    12, 2004) Children who have severe allergic reactions when stung by bees, wasps and other insects should receive venom immunotherapy, or allergy shots, to reduce the chance of future life-threatening reactions. (Oct. (Science Daily)

    Washington Univ. awards $150,000 in Bear Cub Fund grants  Jun 26, 2008
    Linette will use his grant to make adoptive T cell immunotherapy a reality for patients with infectious diseases and cancer. The Bear Cub grant will help Moran's developed microelectrode to be fabricated, implanted in the sciatic nerves of rats and evaluated. (St. Louis Business Journal, MO)

    Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies  Jun 26, 2008
    Antigen Express has previously identified a novel peptide vaccine for melanoma and published its findings in an article titled, ``Enhanced CD4+ T-Cell Response in DR4-Transgenic Mice to a Hybrid Peptide Linking the Ii-Key Segment of the Invariant Chain to the Melanoma gp100(48-58) MHC Class II Epitope,'' in the Journal of Immunotherapy, volume 28, pages 352-358, 2005. We are excited to begin the process of moving this into the clinic with Dr. Markovic,'' said Dr. Eric von Hofe, President of... (Primezone Releases)

    Cancer beaten by dose of own cells  Jun 20, 2008
    The director of the Sydney Melanoma Unit, John Thompson, said a positive response in one patient from the immunotherapy was encouraging. "But ... it will require a lot more work to see if it is reproducible.". (Sydney Morning Herald -- Australia)

    Experimental Therapy Beats Back One Patient's Melanoma  Jun 20, 2008
    Immunotherapy, which engages a patient's own immune system to fight cancer, is an emerging art and science ... And therein lies a major problem with immunotherapy as it exists now ... "Obviously there's a lot of promise for immunotherapy of this kind but I think that we're several years away from making this any kind of standard therapy," Yee said. (MEDLINEplus)

    Man's Melanoma Thwarted by Immune Fix  Jun 20, 2008
    "There are many other immunotherapy treatments that we're not doing, that other people are doing, that probably deserve more attention." ... T-cell therapy is "promising," but there are "many other examples of effective cancer immunotherapy," writes editorialist Louis M. Weiner, MD, director of Georgetown University's Lombardi Comprehensive Cancer Center. (WebMD)

    Terminal Skin Cancer Patient Saved By Treatment Co-Authored By Seattle Doctor  Jun 20, 2008
    But Dr. Darrell Rigel, a dermatology researcher at the New York University Cancer Institute, says immunotherapy has become the most promising approach to late-stage skin cancers. Two years after his remarkable recovery, the patient fell out of contact with researchers and scientists do not know his current condition. (KIRO TV, WA)

    Small success with immunotherapy in skin cancer study  Jun 20, 2008
    "Immunotherapy has become the most promising approach" to late-stage, death-sentence skin cancers, said Dr. Darrell Rigel, a clinical professor of dermatology at the Medical Center in who had no role in the research. Still, the immune-priming experiments have yet to yield a consistent therapy. (Newsday)

    Allergy expert has advice for flood victims  Jun 20, 2008
    If a doctor confirms that health symptoms stem from a reaction to mold, medical treatments are effective: those can be pharmacotherapy which may include antihistamines or steroids, given intranasally or orally or if necessary, immunotherapy, often called allergy shots, which allow your immune system to build up a tolerance to the allergen. But Wedner emphasizes that the source of the reaction, the mold itself, also has to be removed. (EurekAlert!)

    Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation  Jun 19, 2008
    Using a patient's own immune system to combat cancer, called immunotherapy, is a growing area of research that aims to develop less-toxic cancer treatments than standard chemotherapy and radiation. The patient in the journal report was one of nine patients with metastatic melanoma who were being treated in a recently completed clinical trial to test dose-escalation of autologous CD4+ T cells. (PR Newswire)

    Archives: Immunotherapy

    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009